Funder: Colorectal Cancer Alliance
Due Dates: Temporarily suspended (Alliance Research Grant Program); reopening date not announced
Funding Amounts: Up to $200,000 or $500,000 over two years, depending on award category
Summary: Supports innovative colorectal cancer research, from original early-stage projects and proof-of-concept studies to transformative therapies and multidisciplinary team science.
Key Information: Future funding depends on available resources and alignment with Project Cure CRC’s adaptive clinical trial platform.
Description
The Colorectal Cancer Alliance’s Research Grant Program supports investigators and multidisciplinary teams advancing colorectal cancer (CRC) research. Its four accelerator award categories cover original preclinical, translational, and early clinical projects; transformative research on localized or metastatic CRC; high-risk, high-reward proof-of-concept studies; and collaborative research aimed at curative science and innovation.
The program is temporarily suspended while the Alliance focuses resources on establishing an adaptive clinical trial platform under Project Cure CRC. Future research funding will depend on available resources and alignment with that strategic priority. Investigators with concepts that may fit the platform are invited to contact the Alliance’s research team. Project Cure CRC seeks breakthroughs in diagnosis, treatment, metastasis, and survivorship to accelerate progress toward curing colorectal cancer.
